In RFK Jr., drugmakers face an antagonist with regulatory power
- Posted on November 15, 2024
- By Washington Post
- 3 Views
In RFK Jr., drugmakers face an antagonist with regulatory power
Anxious and bewildered, some drugmakers are reaching out to their lobbyists about how Robert Kennedy’s pending nomination will affect the Food and Drug Administration.
